Cargando…
IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
BACKGROUND: Increased interferon (IFN)-gamma inducible protein-10 (IP-10) level has been shown to be associated with sustained virologic responses (SVRs) to pegylated interferon-alpha 2a/ribavirin-based therapy in patients with chronic hepatitis C (CHC). We investigated the relationship between IP-1...
Autores principales: | Wang, Yadong, Hu, Yangyang, Zhang, Xing, Luo, Yue, Ma, Luyuan, Lu, Jingjing, Liang, Qianfei, Xu, Chengjun, Zhao, Caiyan, Pan, Calvin Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342904/ https://www.ncbi.nlm.nih.gov/pubmed/35923969 http://dx.doi.org/10.3389/fpubh.2022.911551 |
Ejemplares similares
-
Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C
por: McGlynn, Elizabeth A., et al.
Publicado: (2019) -
Hepatitis-Induced Porphyria: Are Direct-Acting Antiviral Agents the Way of the Future?
por: John, Jason J., et al.
Publicado: (2021) -
Long-acting antiviral agents for HIV treatment
por: Margolis, David A., et al.
Publicado: (2015) -
Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus
por: Kanda, Tatsuo, et al.
Publicado: (2015) -
Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection
por: Kanda, Tatsuo, et al.
Publicado: (2014)